19 June 2013
Keywords: merck, co, gets, approval, new, antifungal, agent
Article | 30 January 2001
Merck & Co has been granted its first marketing approval, in the USA,for Cancidas (caspofungin acetate), a new intravenous antifungal ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
31 January 2001
29 January 2001
1 February 2001
© 2013 thepharmaletter.com